BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34340288)

  • 1. Letter to the Editor Regarding "Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years".
    Mathon B; Marijon P; Riche M; Amelot A;
    World Neurosurg; 2021 Aug; 152():242-243. PubMed ID: 34340288
    [No Abstract]   [Full Text] [Related]  

  • 2. In Reply to the Letter to the Editor Regarding "Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years".
    Maria Callovini G; Sherkat S; Gazzeri R; Telera S
    World Neurosurg; 2021 Aug; 152():244. PubMed ID: 34340289
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
    Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
    World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with 102 Frameless Stereotactic Biopsies Using the neuromate Robotic Device.
    Yasin H; Hoff HJ; Blümcke I; Simon M
    World Neurosurg; 2019 Mar; 123():e450-e456. PubMed ID: 30500594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique.
    Woodworth GF; McGirt MJ; Samdani A; Garonzik I; Olivi A; Weingart JD
    J Neurosurg; 2006 Feb; 104(2):233-7. PubMed ID: 16509497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients.
    Kiesel B; Millesi M; Woehrer A; Furtner J; Bavand A; Roetzer T; Mischkulnig M; Wolfsberger S; Preusser M; Knosp E; Widhalm G
    Neurosurg Focus; 2018 Jun; 44(6):E7. PubMed ID: 29852770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New developments in diagnosis and therapy of primary non-Hodgkin's lymphoma of the central nervous system].
    Schabet M; Herrlinger U; Weller M; Barnberg M; Clemens R; Dichgans J
    Nervenarzt; 1997 Apr; 68(4):298-308. PubMed ID: 9273459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
    Cheng G; Zhang J
    Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-type primary lymphoma of the central nervous system in immunocompetent patients].
    Barrena-Caballo MR; Blanch-Labrador M; Giménez-Mas JA; Alberdi-Viñas J; Pascual-Piazuelo M; Zubiri-Ara L
    Rev Neurol; 2003 Jan 16-31; 36(2):125-30. PubMed ID: 12589598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microrecording and image-guided stereotactic biopsy of deep-seated brain tumors.
    Iijima K; Hirato M; Miyagishima T; Horiguchi K; Sugawara K; Hirato J; Yokoo H; Yoshimoto Y
    J Neurosurg; 2015 Oct; 123(4):978-88. PubMed ID: 25816085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, Safety, and Duration of a Frameless Fiducial-Less Brain Biopsy versus Frame-based Stereotactic Biopsy: A Prospective Randomized Study.
    Georgiopoulos M; Ellul J; Chroni E; Constantoyannis C
    J Neurol Surg A Cent Eur Neurosurg; 2018 Jan; 79(1):31-38. PubMed ID: 28605819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
    Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
    BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d'étude des Leucénies et Autres Maladies du Sang (GOELAMS).
    Camilleri-Broët S; Martin A; Moreau A; Angonin R; Hénin D; Gontier MF; Rousselet MC; Caulet-Maugendre S; Cuillière P; Lefrancq T; Mokhtari K; Morcos M; Broët P; Kujas M; Hauw JJ; Desablens B; Raphaël M
    Am J Clin Pathol; 1998 Nov; 110(5):607-12. PubMed ID: 9802345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor Regarding "Natalizumab-Associated Primary Central Nervous System Lymphoma".
    Sartori D; Grundmark B
    World Neurosurg; 2018 Jul; 115():473-474. PubMed ID: 29958368
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.
    Velasco R; Mercadal S; Vidal N; Alañá M; Barceló MI; Ibáñez-Juliá MJ; Bobillo S; Caldú Agud R; García Molina E; Martínez P; Cacabelos P; Muntañola A; García-Catalán G; Sancho JM; Camro I; Lado T; Erro ME; Gómez-Vicente L; Salar A; Caballero AC; Solé-Rodríguez M; Gállego Pérez-Larraya J; Huertas N; Estela J; Barón M; Barbero-Bordallo N; Encuentra M; Dlouhy I; Bruna J; Graus F;
    J Neurooncol; 2020 Jul; 148(3):545-554. PubMed ID: 32524392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma Knife radiosurgery in AIDS-related primary central nervous system lymphoma.
    Nicolato A; Gerosa MA; Foroni R; Piovan E; Zampieri PG; Pasoli A; Giri MG; Iuzzolino P; Ghimenton C; Luzzati R
    Stereotact Funct Neurosurg; 1995; 64 Suppl 1():42-55. PubMed ID: 8584839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary central nervous system lymphoma.
    Bhagavathi S; Wilson JD
    Arch Pathol Lab Med; 2008 Nov; 132(11):1830-4. PubMed ID: 18976024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frame-based stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy.
    Smith JS; Quiñones-Hinojosa A; Barbaro NM; McDermott MW
    J Neurooncol; 2005 Jun; 73(2):173-9. PubMed ID: 15981109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advantages of frameless stereotactic biopsy over frame-based biopsy.
    Dorward NL; Paleologos TS; Alberti O; Thomas DG
    Br J Neurosurg; 2002 Apr; 16(2):110-8. PubMed ID: 12046728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of frameless and frame-based intracranial biopsy techniques.
    Dammers R; Haitsma IK; Schouten JW; Kros JM; Avezaat CJ; Vincent AJ
    Acta Neurochir (Wien); 2008 Jan; 150(1):23-9. PubMed ID: 18172567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.